PRELUDE THERAPEUTICS INC (PRLD) Net Margin
- 2026-06-30: Net Margin -244.06%.
- 2026-03-31: Net Margin -226.75%.
- 2025-12-31: Net Margin -291.79%.
- 2025-09-30: Net Margin -303.46%.
Complete source-backed net margin history.
- Available history
- 2024-09-30 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -244.06% |
| 2026-03-31 | -226.75% |
| 2025-12-31 | -291.79% |
| 2025-09-30 | -303.46% |
| 2024-12-31 | -718.28% |
| 2024-09-30 | -1075.70% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -819.59% |
| 2024-12-31 | -1816.76% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |